Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MyAndroferti
- Development stage
- Unknown
- Lead developer
- Aytu BioPharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MyAndroferti is an oral male fertility dietary supplement marketed as Androferti and developed by Innovus Pharma to support male reproductive health, particularly in men with poor sperm quality. It is positioned as a nutraceutical rather than a pharmaceutical drug and is intended to improve semen parameters such as sperm count, concentration, motility, speed, and morphology. Based on the provided context, the product contains L-carnitine, an amino acid commonly used in fertility supplements, with its proposed activity centered on metabolic support for sperm function and improvement of sperm movement rather than a defined single-target pharmaceutical mechanism.
- Brand names
- MyAndrofertiAndroferti
Beyond the preview
Go deeper on MyAndroferti.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MyAndroferti.